Sucampo Pharmaceuticals, Inc. Stock

Stocks

27/12/17	Wall Street slips on tech sector weakness	RE
26/12/17	Mallinckrodt : to buy Sucampo for about $840 million	RE
10/11/16	Boeing : U.S. companies react cautiously to Trump victory	RE

03/01/18	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
29/12/17	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU
28/12/17	CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
28/12/17	SUCAMPO PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
28/11/17	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	GL

27/12/17	Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
26/12/17	Apple : Les valeurs à suivre à Wall Street
08/12/17	Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
08/12/17	Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
19/04/17	Sucampo Pharmaceuticals : Veröffentlichung einer neuen Studie zu VTS-270 für die Behandlung von Morbus Niemann-Pick Typ C1 im Online-Fachjournal PLOS ONE Advances Science

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUCAMPO PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	+0.79%	-6.46%	+52.86%	+71.34%	65.83B
LONZA GROUP AG	+1.92%	+10.35%	+13.02%	+87.74%	51.87B
ARGENX SE	+6.91%	+8.57%	+6.88%	+72.12%	51.2B
IQVIA HOLDINGS INC.	+0.70%	+2.48%	+25.99%	+44.91%	43.76B
BEONE MEDICINES AG	+3.60%	+9.88%	+20.39%	+132.17%	42.09B
REVOLUTION MEDICINES, INC.	+7.96%	+4.11%	+263.24%	+601.41%	39.04B
CELLTRION, INC.	-0.40%	+9.42%	+18.44%	+59.06%	34B
WUXI BIOLOGICS (CAYMAN) INC.	+3.84%	-4.94%	+42.35%	+8.92%	25.2B
GENMAB A/S	+2.36%	+5.34%	+30.98%	+26.07%	22.8B
Average	+2.78%	+0.63%	+52.68%	+122.64%	41.76B
Weighted average by Cap.	+3.04%	+0.74%	+51.04%	+124.47%